GT Biopharma Long Term Deferred Assets (Quarterly) Analysis

GT Biopharma, Inc. (GTBP)

0.4203 -0.04 (-8.63%) USD | NASDAQ | Feb 23, 13:31

View Long Term Deferred Assets (Quarterly) for GTBP.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

SELLAS Life Sciences Group, Inc.	--
Lyell Immunopharma, Inc.	--
Geron Corp.	--
Regeneron Pharmaceuticals, Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	--